You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vilanterol

Showing 1 - 25 of 153
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Exercise Performance Trial in Copenhagen (Vilanterol and Fluticasone Furoate (low dose), Vilanterol and Fluticasone Furoate

Recruiting
  • Exercise Performance
  • Vilanterol and Fluticasone Furoate (low dose)
  • +2 more
  • Copenhagen, DK, Denmark
    August Krogh Building
Sep 27, 2023

Exercise Performance Trial in Copenhagen (Vilanterol and Fluticasone Furoate, Indacaterol and Mometasone Furoate, Placebo)

Recruiting
  • Exercise Performance
  • Vilanterol and Fluticasone Furoate
  • +2 more
  • Copenhagen, Denmark
    August Krogh Building
Oct 4, 2023

Using US Medical and Pharmacy Claim Records to Compare Resource

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Trelegy Ellipta
  • +3 more
  • Eden Prairie, Minnesota
    Optum
Mar 11, 2022

Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI)

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • (no location specified)
Sep 7, 2022

COPD Trial in Mexico City (Fluticasone Furoate/Vilanterol 100/25 mcgs, Umeclidinium/Vilanterol 62.5/25 mcgs)

Completed
  • COPD
  • Fluticasone Furoate/Vilanterol 100/25 mcgs
  • Umeclidinium/Vilanterol 62.5/25 mcgs
  • Mexico City, Tlalpan, Mexico
    National Institute of Respiratory Diseases 'Ismael Cosío Villega
Apr 18, 2022

Replication of the IMPACT COPD Trial in Healthcare Claims Data

Completed
  • COPD
  • Boston, Massachusetts
    Brigham and Women's Hospital
Sep 20, 2021

Pharmacokinetics Trial in Copenhagen (Fluticasone Furoate/ Vilanterol Trifenatate)

Completed
  • Pharmacokinetics
  • Fluticasone Furoate/ Vilanterol Trifenatate
  • Copenhagen, Denmark
    Respiratory research unit, Bispebjerg University Hospital
Jan 26, 2021

Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI, ELLIPTA)

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • (no location specified)
Aug 15, 2022

Copd, Heart Failure Trial (Umeclidinium/vilanterol, Placebo)

Not yet recruiting
  • Copd
  • Heart Failure
  • (no location specified)
Feb 17, 2021

COPD Trial in Keswick (Anoro Ellipta, Arnuity Ellipta)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Anoro Ellipta
  • Arnuity Ellipta
  • Keswick, Virginia
    Roselove NUNOO-ASARE
May 3, 2022

COPD Trial in Godollo (BDP/FF/GB, FlF/VI + Tiotropium)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Godollo, Hungary
    Erzsebet Gondozohaz
Oct 28, 2021

Asthma in Children Trial in Haifa (Fluticasone furoate (FF)/Vilanterol (VI), Salbutamol)

Completed
  • Asthma in Children
  • Haifa, Israel
    Rambam Medical Center
Feb 10, 2021

COPD Trial (Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg, Fluticasone Furoate / Vilanterol

Withdrawn
  • COPD
  • Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg
  • Fluticasone Furoate / Vilanterol Trifenatate 100/25 mcg
  • (no location specified)
Jan 19, 2022

Based on Medical Records That Looks at Duration of Use of Two

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Olodaterol/Tiotropium Bromide
  • Umeclidinium/ Vilanterol
  • New York, New York
    Aetion Inc.
Nov 12, 2021

US Based on Pharmacy and Medical Claims That Compares How Well

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Trelegy Ellipta
  • +3 more
  • White Plains, New York
    eMax health
Jan 11, 2022

COPD, Non Small Cell Lung Cancer Trial in Seoul (Vilanterol and Umeclidinium Bromide, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Non Small Cell Lung Cancer
  • Vilanterol and Umeclidinium Bromide
  • Placebo
  • Seoul, Korea, Republic of
    Samsung Medical Center
Apr 1, 2021

Asthma Trial in China (FF/VI, FF/UMEC/VI, ELLIPTA)

Recruiting
  • Asthma
  • Xiamen, Fujian, China
  • +40 more
Oct 25, 2022

COPD Trial in Germany, United Kingdom (AZD8871, Anoro® Ellipta®)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Berlin, Germany
  • +4 more
Nov 24, 2020

Pulmonary Disease, Chronic Obstructive Trial in Waterbury, Charlotte, Layton (Inhaled corticosteroids/long-acting

Withdrawn
  • Pulmonary Disease, Chronic Obstructive
  • Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists
  • Fluticasone furoate/umeclidinium/vilanterol
  • Waterbury, Connecticut
  • +2 more
Apr 21, 2020

COPD Trial in United Kingdom (Tiotropium & olodaterol, fluticasone furoate & vilanterol)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Tiotropium & olodaterol
  • fluticasone furoate & vilanterol
  • Dundee, United Kingdom
  • +3 more
Jul 16, 2020

Asthma Trial in Japan (FF/UMEC/VI 100/62.5/25 mcg, FF/UMEC/VI 200/62.5/25 mcg, Salbutamol)

Completed
Has Results
  • Asthma
  • FF/UMEC/VI 100/62.5/25 mcg
  • +3 more
  • Gifu, Japan
  • +12 more
May 14, 2020

Asthma Trial (FF/UMEC/VI, ELLIPTA, FF/VI)

Not yet recruiting
  • Asthma
  • (no location specified)
Feb 24, 2023

Pulmonary Disease, Chronic Obstructive Trial in Poland, Russian Federation, United States (FF/UMEC/VI, Tiotropium,

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Andalusia, Alabama
  • +71 more
Jul 13, 2021

Asthma Trial in Worldwide (FF/VI via ELLIPTA DPI, FF via ELLIPTA DPI)

Completed
Has Results
  • Asthma
  • FF/VI via ELLIPTA DPI
  • FF via ELLIPTA DPI
  • Hoover, Alabama
  • +183 more
Sep 12, 2022

Copd Trial in Dallas (TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation)

Not yet recruiting
  • Copd
  • TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation
  • Dallas, Texas
    Baylor Scott & White Health Research Institute
Mar 22, 2022